Farah Ali
No ORCID on file
· 1 paper in corpus
article
2020
Background and objectiveElagolix is an oral, non-peptide, gonadotropin-releasing hormone receptor antagonist. It is approved for the treatment of moderate-to-severe pain associated with endometriosis and is being investigated for the treatm…